Compare · MAMO vs STE
MAMO vs STE
Side-by-side comparison of Massimo Group (MAMO) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- MAMO operates in Consumer Discretionary, while STE operates in Health Care - the two are in different parts of the market.
- STE is the larger of the two at $24.74B, about 734.3x MAMO ($33.7M).
- Over the past year, MAMO is down 75.8% and STE is down 0.8% - STE leads by 75.1 points.
- STE has been more active in the news (13 items in the past 4 weeks vs 4 for MAMO).
- STE has more recent analyst coverage (18 ratings vs 0 for MAMO).
- Company
- Massimo Group
- STERIS plc (Ireland)
- Price
- -
- $254.91-1.74%
- Market cap
- $33.7M
- $24.74B
- 1M return
- -4.93%
- +15.09%
- 1Y return
- -75.84%
- -0.78%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 2024
- News (4w)
- 4
- 13
- Recent ratings
- 0
- 18
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest MAMO
- Massimo Group Expands Marine Portfolio with New Cove Series Entry-Level Boats
- Massimo Group Officially Launches Warrior 1500XD and Sentinel 1500 HVAC Crew at 2026 SEMA Show
- Massimo Group filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Massimo Group Reports Strong Dealer Response to New Warrior 1500XD and Sentinel 1500 HVAC Crew Following Equip Exposition Debut
- Massimo Group Announces Exclusive 2027 Buck 570 UTV Developed for Major National Retailer
- SEC Form 8-K filed by Massimo Group
- Massimo Group Launches Retro-Inspired Mini Truck Exclusively at Tractor Supply for 2026 Holiday Season
- Massimo Group to Unveil New Warrior 1500 UTV at Equip Exposition and Showcase Next-Generation Product Platform at 2026 SEMA Show
- Massimo Group Adds Navy MWR as Fleet Customer, Expanding Government and Military-Related Sales Channel
- SEC Form 10-Q filed by Massimo Group
Latest STE
- Sr. VP and GM, Life Sciences Julia Madsen sold $531,960 worth of Ordinary Shares (2,046 units at $260.00), decreasing direct ownership by 17% to 10,211 units (SEC Form 4)
- Steris upgraded by Jefferies with a new price target
- Director Sohi Mohsen exercised 4,893 units of Ordinary Shares at a strike of $114.74 and sold $1,239,008 worth of Ordinary Shares (4,893 units at $253.22) (SEC Form 4)
- Sr. Vice Pres., CFO Burton Karen L exercised 5,880 units of Ordinary Shares at a strike of $147.05 and sold $1,503,046 worth of Ordinary Shares (5,880 units at $255.62) (SEC Form 4)
- STERIS plc (Ireland) filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 144 filed by STERIS plc (Ireland)
- SEC Form 144 filed by STERIS plc (Ireland)
- SEC Form 10-Q filed by STERIS plc (Ireland)
- STERIS plc (Ireland) filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- STERIS plc (Ireland) filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits